|
Asia-Pacific Economic Cooperation (APEC) Cervical Cancer Initiative
|
Meeting/ Workshop
|
OS
|
NCI
|
On August 24-25, 2017, the US National Cancer Institute’s Center for Global Health (NCI/CGH), working in collaboration with the US Departments of State and Health and Human Services, led a Policy Dialogue and Workshop on Human Papillomavirus (HPV) and Cervical Cancer Control during the APEC meetings in Ho Chi Minh City, Vietnam. The primary goal this dialogue was to jointly promote strategies for implementation of the APEC Roadmap to Promote Sustainable Economic Advancement for Women through Cervical Cancer Prevention and Control (2016-2021), a guiding document approved by the APEC Health Working Group in early 2017 with a key goal of enhancing knowledge exchange opportunities. Specifically, this practical workshop focused on current evidence of cost-effectiveness and the investment benefits of HPV vaccination programs as well as how to collect and use data from pilot and large-scale programs to inform future decision-making.
|
|
Assay Guidance Workshop For High Throughput Screening And Lead Discovery
|
Meeting/ Workshop
|
FDA
|
NCATS, NCI, NIAAA, NIDDK
|
More than 40 participants attended the “Assay Guidance Workshop for High-Throughput Screening and Lead Discovery” on August 7, 2017, in Potomac, Maryland. Supported by NCATS, the workshop was designed to provide participants with a broad and practical perspective on how to develop and implement robust assays for early-stage drug discovery projects. Participants included researchers from four NIH centers, FDA, industry, and academia. Workshop leaders with more than 20 years of drug discovery experience covered a broad range of critical concepts underlying robust assay development and screening strategies. There were also open discussions for participants to share experiences and seek practical advice about individual research interests.
|
|
Assessment of Occupational Exposure to Coal Tar Pitch Volatiles Containing Polycyclic Aromatic Hydrocarbons (PAHs) in Coal Tar Sealant Applications
|
Research Initiative
|
CDC
|
NIEHS
|
This study is to conduct exposure assessment in occupational populations for chemicals of interest to the National Toxicology Program.
|
|
Assessment of Occupational Exposure to Flame Retardants
|
Research Initiative
|
CDC
|
NIEHS
|
Conduct exposure assessment in occupational populations for chemicals of interest to the National Toxicology Program.
|
|
Assisted Outpatient Treatment
|
Research Initiative
|
HRSA, SAMHSA
|
NIMH
|
This collaboration supports the development and implementation of a rigorous and objective cross-site impact evaluation of an Assisted Outpatient Treatment (AOT) Grant Program for Individuals with Serious Mental Illness. The Department of Health and Human Services, Assistant Secretary for Planning and Evaluation (ASPE) has primary responsibility for the solicitation, management, and implementation of the evaluation contract in consultation with the Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institute of Mental Health (NIMH). The Center for Behavioral Health Statistics and Quality (CBHSQ), an entity within SAMHSA that serves as a focal point for data collection, analysis, and the dissemination of critical public health data, will provide consultation on the cross-site evaluation of the AOT grant program. ASPE, in consultation with the NIMH, brings expertise in evaluation design and implementation that benefits SAMHSA in its priority of having a rigorous multi-site evaluation. The initial Phase I Implementation Evaluation was completed in FY2017. Results of the Implementation Evaluation will inform the data collection plan for the Phase II Outcome Evaluation, which is scheduled to begin in FY2018.
|
|
Association Between Urinary PAH and Esophageal Squamous Dysplasia in the STEP study in Western Kenya
|
Research Initiative
|
CDC
|
NCI
|
This activity is a collaboration between NCI and CDC that aims to measure metabolites of polycyclic aromatic hydrocarbons (PAHs), cotinine and creatinine in the urine samples from individuals with and without precancerous lesions of the esophagus.
|
|
ASTM International F-2529-13--Standard Guide for In-Vivo Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone (DBM)
|
Research Initiative
|
FDA
|
NIDCR
|
Provide a guide based on a consensus of viewpoints used to determine the osteoinductive potential of a DBM containing products utilizing the arrhythmic rodent model.
|
|
Autoimmune Diseases Coordinating Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NIAID, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
The purpose of the Autoimmune Diseases Coordinating Committee (ADCC) is to provide a forum for the coordination of research efforts in autoimmunity and autoimmune diseases among various stakeholders including the NIH, other federal agencies such as the FDA and the CDC, and private organizations with an interest in autoimmune diseases. The ADCC meets twice yearly to discuss a broad range of basic, preclinical, and clinical endeavors.
|
|
Bacteriophage Therapy: Scientific and Regulatory Issues Public Workshop
|
Meeting/ Workshop
|
FDA
|
NIAID
|
The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with bacteriophage therapy.
|
|
Best Pharmaceuticals for Children Act (BPCA) Data Monitoring Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD
|
The Best Pharmaceuticals for Children Act (BPCA) Data Coordinating Center (DCC) is responsible for managing all aspects of BPCA clinical trials including developing trial design, collecting and analyzing trial data, monitoring data quality, conducting site monitoring, collecting and preparing safety reports, organizing and submitting documentation to the FDA, and managing the Data Monitoring Committee.
|